Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
In the latest session, Agios Pharmaceuticals Inc (NASDAQ: AGIO) closed at $36.07 up 2.04% from its previous closing price of $35.35. In other words, the price has increased by $2.04 from its previous closing price. On the day, 0.26 million shares were traded. AGIO stock price reached its highest trading level at $36.145 during the session, while it also had its lowest trading level at $35.12.
Ratios:
For a deeper understanding of Agios Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.93 and its Current Ratio is at 18.50. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on February 24, 2025, initiated with a Buy rating and assigned the stock a target price of $58.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 01 ’25 when Gheuens Sarah sold 4,091 shares for $34.17 per share. The transaction valued at 139,789 led to the insider holds 61,271 shares of the business.
Gheuens Sarah bought 4,091 shares of AGIO for $140,608 on Jul 01 ’25. On Jun 24 ’25, another insider, Burns James William, who serves as the Chief Legal Officer of the company, sold 2,799 shares for $33.54 each. As a result, the insider received 93,878 and left with 28,650 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AGIO now has a Market Capitalization of 2089001216 and an Enterprise Value of 1085824512. As of this moment, Agios’s Price-to-Earnings (P/E) ratio for their current fiscal year is 3.20. For the stock, the TTM Price-to-Sale (P/S) ratio is 56.41 while its Price-to-Book (P/B) ratio in mrq is 1.42. Its current Enterprise Value per Revenue stands at 29.319 whereas that against EBITDA is -2.498.
Stock Price History:
The Beta on a monthly basis for AGIO is 0.79, which has changed by -0.154279 over the last 52 weeks, in comparison to a change of 0.12792087 over the same period for the S&P500. Over the past 52 weeks, AGIO has reached a high of $62.58, while it has fallen to a 52-week low of $23.42. The 50-Day Moving Average of the stock is 14.04%, while the 200-Day Moving Average is calculated to be -3.71%.
Shares Statistics:
For the past three months, AGIO has traded an average of 596.80K shares per day and 551680 over the past ten days. A total of 57.89M shares are outstanding, with a floating share count of 55.39M. Insiders hold about 4.37% of the company’s shares, while institutions hold 105.23% stake in the company. Shares short for AGIO as of 1749772800 were 4323656 with a Short Ratio of 7.24, compared to 1747267200 on 4158016. Therefore, it implies a Short% of Shares Outstanding of 4323656 and a Short% of Float of 7.5200000000000005.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
